Tempest Therapeutics, Inc. Common Stock (TPST)
Tempest Therapeutics, Inc. (TPST) is a clinical-stage biotechnology company focused on developing targeted cancer therapies. The company aims to identify and advance novel immuno-oncology and targeted agents, leveraging a deep understanding of tumor biology to create treatments that improve patient outcomes.
Company News
The advanced liver cancer market is positioned for strong growth, with over 50 companies developing 52+ pipeline drugs, focusing on innovative targeted therapies and immuno-oncology combinations to improve treatment outcomes.
The article discusses recent insider trading activities in three penny stocks: Allied Gaming & Entertainment, Archer Aviation, and Tempest Therapeutics. Insiders have been aggressively buying shares in these companies, indicating their confidence in the companies' prospects.
5 hot penny stocks to watch this week. Time to buy now or avoid entirely? The post Penny Stocks To Buy? 5 To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
On a day of rising geopolitical tensions, this technical strategist says there are plenty of reasons to be optimistic about stocks
Tempest (TPST) skyrockets 2879% on positive new and updated findings from its early-mid-stage study evaluating TPST-1120 in combination with standard-of-care therapies to treat liver cancer.